(Q38022224)

27 August 2017

title

The effect of metformin on insulin resistance and exercise parameters in patients with heart failure (English)

1 reference

27 August 2017

0 references

1 reference

1 reference

8

1 reference

27 August 2017

Chim C Lang

9

0 references

author name string

Aaron K F Wong

1

1 reference

27 August 2017

Ruth Symon

2

1 reference

27 August 2017

Matlooba A AlZadjali

3

1 reference

27 August 2017

Donald S C Ang

4

1 reference

27 August 2017

Simon Ogston

5

1 reference

27 August 2017

AnnaMaria Choy

6

1 reference

27 August 2017

John R Petrie

7

1 reference

27 August 2017

language of work or name

1 reference

27 June 2012

1 reference

European Journal of Heart Failure

27 August 2017

published in

1 reference

27 August 2017

volume

14

1 reference

27 August 2017

issue

11

1 reference

27 August 2017

page(s)

1303-1310

1 reference

Insulin resistance: a potential new target for therapy in patients with heart failure

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS106

Insulin resistance is highly prevalent and is associated with reduced exercise tolerance in nondiabetic patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS106

Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS106

Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS106

Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS106

Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS106

Effect of Metformin on mortality in patients with heart failure and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS106

Prognostic significance and measurement of exercise-derived hemodynamic variables in patients with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS106

Exercise anaerobic threshold and ventilatory efficiency identify heart failure patients for high risk of early death

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS106

Development of a ventilatory classification system in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS106

The differential effects of metformin on markers of endothelial activation and inflammation in subjects with impaired glucose tolerance: a placebo-controlled, randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS106

Ease of noninvasive measurement of cardiac output coupled with peak VO2 determination at rest and during exercise in patients with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS106

Oral glucose tolerance testing in an outpatient heart failure clinic reveals a high proportion of undiagnosed diabetic patients with an adverse prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS106

Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS106

Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS106

Metformin treatment in diabetes and heart failure: when academic equipoise meets clinical reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS106

Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS106

Impact of metformin on peak aerobic capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS106

Effect of Orlistat in obese patients with heart failure: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS106

Insulin resistance and maximal oxygen uptake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS106

Rosiglitazone improves exercise capacity in individuals with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS106

Modulation of insulin activities by leptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS106

Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not to norepinephrine or TNF-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS106

Leptin inhibits glycogen synthesis in the isolated soleus muscle of obese (ob/ob) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS106

Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS106

Metformin inhibits leptin secretion via a mitogen-activated protein kinase signalling pathway in brown adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS106

Circulating adiponectin concentrations in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS106

Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS106

Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS106

Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS106

Serum resistin is associated with high risk in patients with congestive heart failure--a novel link between metabolic signals and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS106

Resistin, obesity, and insulin resistance--the emerging role of the adipocyte as an endocrine organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS106

Energy metabolism in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS106

Improved endothelial function with metformin in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS106

Metformin improves endothelial function in patients with metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS106

Effects of pioglitazone and metformin on vascular endothelial function in patients with type 2 diabetes treated with sulfonylureas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS106

Prognostic significance of different measures of the ventilation-carbon dioxide relation in patients with suspected heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS106

Usefulness of Non-Invasive Measurement of Cardiac Output During Sub-Maximal Exercise to Predict Outcome in Patients With Chronic Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS106

21 January 2018

Identifiers

DOI

10.1093/EURJHF/HFS106

1 reference

27 August 2017

1 reference